Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Baseline Blood Indices as a Marker for Prolonged Length of Hospital Stay in Diabetic Older Patients With Mild or Moderate Covid-19 Infection

NCT05054283 is registered in ClinicalTrials.gov with Gulhane Training and Research Hospital as lead sponsor.

NCT NCT05054283
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05054283 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Baseline Blood Indices as a Marker for Prolonged Length of Hospital Stay in Diabetic Older Patients With Mild or Moderate Covid-19 Infection
Lead sponsor
Gulhane Training and Research Hospital
Phase
Observational
Overall status
Unknown status
Start date
October 1, 2021
Completion date
December 1, 2021
Enrollment
90 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19 pneumonia, diabetes mellitus, type 2, hospitalism